Jenna Sullivan

Jenna Sullivan has worked in the scientific field since 2006. Jenna began their career at Sanofi Genzyme as a Summer Internship in 2006 and then as a Research Associate (Temporary) in 2007. In 2008, they worked as a Research Technician at Brigham and Women's Hospital in the laboratory of Dr. Vijay Kuchroo, performing research examining T cell pathogenicity and function during EAE and cancer. From 2012 to 2019, they worked as a Graduate Research Student at the University of Washington in the laboratory of Dr. Daniel Campbell, where their thesis work focused on (1) characterization of spontaneous inflammation in a mouse model of Foxo1 dysregulation and (2) transcriptional regulators of tissue resident regulatory T cells (Tregs). In 2019, they moved to the Benaroya Research Institute at Virginia Mason as a Postdoctoral Researcher in the Laboratory of Dr. Daniel Campbell, where their research focused on examining Foxo1 regulation of CD8+ effector T cell differentiation and function. In 2020, they began working at Werewolf Therapeutics as a Scientist and then as a Senior Scientist.

Jenna Sullivan completed a Bachelor of Science in Biology, General from the University of New Hampshire between 2003 and 2007. Jenna then went on to earn a Doctor of Philosophy in Immunology from the University of Washington - School of Medicine between 2012 and 2018.